However, CD34 and CD117 co-expression is not universal in AML-M0, -M1, and/or -M2.35 Thus, this may be a principal explanation why our prevalence estimates for AML subtypes differ from other studies.38 This evidence concerns the gene CD34 and acute myeloid leukemia.